ONCIMMUNE HOLDINGS PLC Logo

ONCIMMUNE HOLDINGS PLC

ONC | IL

Overview

Corporate Details

ISIN(s):
GB00BYQ94H38
LEI:
213800HCYIWT6YPI1I02
Country:
United Kingdom
Address:
CLINICAL SCIENCES BUILDING CITY HOSPITAL, NG5 1PB NOTTINGHAM
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Oncimmune Holdings PLC is a precision medicine company specializing in antibody biomarker discovery to support the development of targeted therapies. Its core offering is the proprietary ImmunoINSIGHTS™ platform, an analytical engine that profiles autoantibodies from minimal biological samples. Leveraging one of the world's largest antigen libraries (over 9000 antigens), high-throughput automated workflows, and advanced bioinformatics, the platform provides insights for pharmaceutical and biotechnology partners. The company's services focus on biomarker discovery and targeted panels for applications in immuno-oncology, autoimmune diseases, and infectious diseases, aiming to enable more effective and safer treatments.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for ONCIMMUNE HOLDINGS PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-03-26 13:45
Legal Proceedings Report
Appointment of Administrators & Nomad Resignation
English 9.0 KB
2025-03-19 08:00
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-03-17 08:00
Delisting Announcement
Intention to Appoint Administrators and Suspension
English 11.4 KB
2025-03-14 08:00
Share Issue/Capital Change
Block Listing Return
English 12.3 KB
2025-03-10 14:39
Post-Annual General Meeting Information
Result of GM
English 14.5 KB
2025-02-27 17:18
Post-Annual General Meeting Information
Result of AGM
English 13.5 KB
2025-02-24 08:00
Business and Financial Review
Strategic update
English 11.1 KB
2025-02-18 08:00
Major Shareholding Notification
Holding(s) in Company
English 23.3 KB
2025-02-12 08:01
Share Issue/Capital Change
Block Listing Return
English 12.3 KB
2025-02-12 08:00
Pre-Annual General Meeting Information
Posting of Notice of General Meeting
English 8.1 KB
2025-02-10 08:00
Earnings Release
Final Results
English 154.5 KB
2025-02-04 11:38
Major Shareholding Notification
Holding(s) in Company
English 23.2 KB
2025-02-03 08:00
Pre-Annual General Meeting Information
Notice of Annual General Meeting
English 8.2 KB
2025-01-31 08:00
Earnings Release
Trading Update
English 13.6 KB
2024-12-10 16:36
Major Shareholding Notification
Holding(s) in Company
English 23.2 KB

Automate Your Workflow. Get a real-time feed of all ONCIMMUNE HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ONCIMMUNE HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN